LA JOLLA, Calif. – Gene therapy has come a long way from using retroviral vectors to insert gamma-chain transgenes into cells of children with severe combined immunodeficiency in the early 1990s, an act that increased the risk of developing leukemia. Read More
SAN FRANCISCO – Since the April 2012 passage of the Jumpstart Our Business Startup (JOBS) Act, the rate of new biotech initial public offerings (IPOs) has nearly tripled, with 115 since enactment, and about 65 this year. Read More
